MedPath

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy

Not Applicable
Completed
Conditions
Milk Hypersensitivity
Protein Allergy
Food Sensitivity
Interventions
Dietary Supplement: extensively hydrolyzed rice protein formula
Registration Number
NCT01998074
Lead Sponsor
United Pharmaceuticals
Brief Summary

The aim of the study is to show the efficacy, tolerance and nutritional adequacy of a newly developed hydrolyzed rice formula in infants with a proven cow's milk protein allergy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Infants between 2 weeks and 6 months old
  • In whom cow's Milk Protein Allergy has been proved by a food challenge performed during the previous month
Exclusion Criteria
  • Exclusively breast fed infants
  • Preterm infants
  • Infants already fed with an extensively hydrolyzed formula with no improvement of the symptoms.
  • Infants fed an amino acid based formula
  • Infants who had an anaphylactic reaction in the past

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Study formulaextensively hydrolyzed rice protein formula-
Primary Outcome Measures
NameTimeMethod
Clinical improvement of symptoms of cow's milk protein allergy, through the use of a validated scoreat 4 weeks
Secondary Outcome Measures
NameTimeMethod
Clinical improvement of symptoms of cow's milk protein allergy, through the use of a validated scoreat 6 months
Growth (weight, height, head circumference)6 months

Trial Locations

Locations (1)

Universitair Ziekenhuis

🇧🇪

Brussel, Belgium

© Copyright 2025. All Rights Reserved by MedPath